Peer Review History
| Original SubmissionSeptember 29, 2025 |
|---|
|
Dear Dr. Hernandez Lucas, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mohammad Faezi Ghasemi, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following financial disclosure: “This work was supported by grants from: Dirección General de Asuntos del Personal Académico (DGAPA/UNAM, IN203621-IN202224) and Consejo Nacional de Humanidades Ciencia y Tecnología (CONAHCYT, CF-2023-I-2079) to I.H.L. V. H was supported by Universidad Nacional Autónoma de México Posdoctotal Programs (POSDOC).” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: “We would like to thank M. Dunn for stimulating discussions and critical reading. M. 476 Fernández-Mora, F. J. Santana and A. Vazquez for scientific suggestions. Alcocer A. 477 and Marcos-Duran J. M. for their technical assistance. This work was supported by 23 478 grants from: Dirección General de Asuntos del Personal Académico (DGAPA/UNAM, 479 IN203621-IN202224) and Consejo Nacional de Humanidades Ciencia y Tecnología 480 (CONAHCYT, CF-2023-I-2079) to I.H.L. V. H was supported by Universidad Nacional 481 Autónoma de México Posdoctoral Programs (POSDOC)” We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This work was supported by grants from: Dirección General de Asuntos del Personal Académico (DGAPA/UNAM, IN203621-IN202224) and Consejo Nacional de Humanidades Ciencia y Tecnología (CONAHCYT, CF-2023-I-2079) to I.H.L. V. H was supported by Universidad Nacional Autónoma de México Posdoctotal Programs (POSDOC).” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Please ensure that you refer to Figure 1, 6, 8 and 9 in your text as, if accepted, production will need this reference to link the reader to the figure. 6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: This manuscript presents a highly comprehensive and systematic functional characterization of 18 previously uncharacterized LysR-Type Transcriptional Regulators (LTTRs) in Salmonella enterica serovar Typhi. The high-throughput approach, covering key virulence-associated phenotypes such as bile tolerance, antimicrobial resistance, motility, and biofilm formation, represents a significant contribution to S. Typhi pathogenesis research. The methodological rigor, particularly the use of non-polar mutagenesis and host-relevant minimal medium, makes this work suitable for publication in PLOS ONE, pending revisions. Overall Assessment: Major Revisions are suggested to enhance the mechanistic depth and structural completeness of the manuscript. Reviewer #2: 1. The authors should clarify whether the identified LTTRs directly regulate ompC and ompF transcription or whether their effects are indirect. Likewise, for biofilm formation and motility, it would strengthen the manuscript to indicate whether specific virulence- or flagellar-related genes are misregulated in the mutants. Including even preliminary data or a focused discussion on potential regulatory targets would greatly enhance the study’s impact. 2. The assignment of mutants into four functional groups appears somewhat arbitrary and is not consistently aligned with the experimental data. For example, the manuscript states that Group II mutants “produced OmpF but not OmpC,” yet the corresponding figures suggest that some Group II strains express both porins, while others like ΔSTY0341 (also classified as Group II) lack OmpF entirely. The authors should carefully re-evaluate this classification using all available phenotypic evidence and provide a clear, data-driven justification for the final groupings. 3. The introduction would benefit from a brief mention of the clinical significance of typhoid fever and the growing challenge of antibiotic resistance. This context would more effectively underscore the relevance of investigating virulence mechanisms in Salmonella typhi. 4. In the discussion, the authors should either temper or remove the claim regarding the global regulon of the transcription factor, as 1D gel electrophoresis alone is insufficient to support such a broad conclusion. A comprehensive assessment of a regulon would require more robust approaches, such as proteomic or transcriptomic analyses. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Ashraf Kariminik ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 1 |
|
Functional role of 18 LysR-Type transcriptional regulators of Salmonella enterica serovar Typhi. PONE-D-25-53096R1 Dear Dr. Hernandez Lucas, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mohammad Faezi Ghasemi, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes ********** Reviewer #2: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: Yes: Ashraf Kariminik ********** |
| Formally Accepted |
|
PONE-D-25-53096R1 PLOS ONE Dear Dr. Hernandez-Lucas, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mohammad Faezi Ghasemi Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .